IDXG首席执行官Thomas Burnell表示,随着交易的完成,公司的运营现金流预计每年将增加近500万美元,且将把出售所得用于满足营运资金需求,并用于投资发展分子诊断业务。
$药明康德(SH603259)$ $泰格医药(SZ...查看全文
Interpace(IDXG)2020-04-18 04:45
$Interpace诊断(IDXG)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-20-000269 Act: 34 Size: 61 KB 网页链接查看全文
Interpace(IDXG)2020-02-11 05:15
$Interpace诊断(IDXG)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001493152-20-001864 Size: 4 KB 网页链接查看全文
Interpace(IDXG)2020-01-24 06:20
$Interpace诊断(IDXG)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001192482-20-000053 Size: 7 KB 网页链接查看全文
Interpace(IDXG)2020-01-24 06:50
$Interpace诊断(IDXG)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001493152-20-000992 Act: 34 Size: 136 KB 网页链接查看全文
Interpace(IDXG)2020-04-07 05:55
$Interpace诊断(IDXG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-20-005921 Size: 4 KB 网页链接查看全文
Interpace(IDXG)2020-01-28 05:40
$Interpace诊断(IDXG)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001493152-20-001162 Act: 33 Size: 16 KB 网页链接查看全文
$Interpace(IDXG)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-21-007927 Act: 34 Size: 131 KB 网页链接
$Interpace(IDXG)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001493152-21-007622 Act: 34 Size: 39 KB 网页链接
$Interpace(IDXG)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-21-007629 Act: 34 Size: 8 MB 网页链接
$Interpace(IDXG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-005913 Size: 7 KB 网页链接
$Interpace(IDXG)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001171520-21-000113 Act: 34 Size: 46 KB 网页链接
$Interpace(IDXG)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001420506-21-000362 Size: 8 KB 网页链接
$Interpace(IDXG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001420506-21-000363 Size: 18 KB 网页链接
$Interpace(IDXG)$ 8-K Current report, items 3.01, 8.01, and 9.01 Accession Number: 0001493152-21-004756 Act: 34 Size: 55 KB 网页链接
$Interpace(IDXG)$ 8-K Current report, items 3.01, 7.01, 8.01, and 9.01 Accession Number: 0001493152-21-004159 Act: 34 Size: 90 KB 网页链接
$Interpace(IDXG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-21-000123 Act: 34 Size: 60 KB 网页链接